Code | 7645E | ||||||||||
MA number | 15/0250/24-S | ||||||||||
Product Form: | plo ijf 5x1 g (lie.inj.skl.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Swyssi AG, Germany | ||||||||||
Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intramuscular or intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 22.10.2024 |
Validity: | 22.10.2029 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric contraindication: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_Ceftriaxón Swyssi 1 g prášok na injekčný_infúzny roztok_10_2024.pdf |
SPC: | SPC_Ceftriaxón Swyssi 1 g prášok na injekčný_infúzny roztok_10_2024.pdf |
Safety feature | Yes |
Data update: | 23.10.2024 |